This study will assess two options to help patients better manage the cognitive fog and
emotional distress that may be associated with having Long-COVID. Long-COVID is post-COVID
conditions or symptoms lasting more than four weeks after infection. Clinicians from the UPMC
Long-COVID Clinic leading this study are evaluating the utility of computer-based evaluation
of COVID-related cognitive fog and the helpfulness of two intervention strategies to treat
moderate cognitive impairment using a randomized trial. The two intervention strategies
include 1) a standardized dosing of amphetamine/dextroamphetamine medication that has been
used to improve cognitive fog; and 2) a digital behavioral tool with an embedded health coach
that is used on a mobile phone.